Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Prostate Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 30 articles: HTML format Text format

Single Articles

April 2012
1. IACOPINO F , Pinto F, Bertaccini A, Calarco A, et al
   Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy.
   Oncol Rep. 2012 Apr 25. doi: 10.3892/or.2012.1785.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. NI X , Zhang A, Zhao Z, Shen Y, et al
   Demethoxycurcumin inhibits cell proliferation, migration and invasion in prostate cancer cells.
   Oncol Rep. 2012 Apr 23. doi: 10.3892/or.2012.1783.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MALARA AE , Fedele C, Aloj L, Arra C, et al
   Effects of a human compact anti-ErbB2 antibody on prostate cancer.
   Oncol Rep. 2012 Apr 10. doi: 10.3892/or.2012.1760.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
4. TAO J , Wu D, Xu B, Qian W, et al
   microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.
   Oncol Rep. 2012 Mar 7. doi: 10.3892/or.2012.1711.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
5. SHAIKHIBRAHIM Z , Ochsenfahrt J, Fuchs K, Wernert N, et al
   Novel identification of the ETS-1 splice variants p42 and p27 in prostate cancer cell lines.
   Oncol Rep. 2012 Feb 1. doi: 10.3892/or.2012.1667.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
6. GUMULEC J , Sochor J, Hlavna M, Sztalmachova M, et al
   Caveolin-1 as a potential high-risk prostate cancer biomarker.
   Oncol Rep. 2011 Dec 8. doi: 10.3892/or.2011.1587.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
7. STEINER I , Jung K, Miller K, Stephan C, et al
   Expression of endothelial factors in prostate cancer: a possible role of caveolin-1 for tumour progression.
   Oncol Rep. 2011 Nov 9. doi: 10.3892/or.2011.1539.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. ZENG R , Liu Z, Sun Y, Xu C, et al
   Differential expression and function of AR isoforms in prostate cancer.
   Oncol Rep. 2011 Oct 21. doi: 10.3892/or.2011.1516.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. BAI WU , Wu ZU, Shen E, Zhang JH, et al
   The improvement of liposome-mediated transfection of pEGFP DNA into human prostate cancer cells by combining low-frequency and low-energy ultrasound with microbubbles.
   Oncol Rep. 2011 Oct 20. doi: 10.3892/or.2011.1510.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. ORZECHOWSKA E , Kozlowska E, Staron K, Trzcinska-Danielewicz J, et al
    Time schedule-dependent effect of the CK2 inhibitor TBB on PC-3 human prostate cancer cell viability.
    Oncol Rep. 2011 Oct 12. doi: 10.3892/or.2011.1500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. FRIEDLANDER TW , Weinberg VK, Huang Y, Mi JT, et al
    A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer.
    Oncol Rep. 2011 Oct 4. doi: 10.3892/or.2011.1487.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
12. QIU J , Gao Z, Shima H
    Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
    Oncol Rep. 2011 Sep 22. doi: 10.3892/or.2011.1470.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
13. ROOMI MW , Kalinovsky T, Rath M, Niedzwiecki A, et al
    Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
    Oncol Rep. 2011 Aug 24. doi: 10.3892/or.2011.1434.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. ZHANG P , He X, Tan J, Zhou X, et al
    beta-arrestin2 mediates beta-2 adrenergic receptor signaling inducing prostate cancer cell progression.
    Oncol Rep. 2011 Aug 10. doi: 10.3892/or.2011.1417.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
15. GEIGER KD , Hendruschk S, Rieber EP, Morgenroth A, et al
    The prostate stem cell antigen represents a novel glioma-associated antigen.
    Oncol Rep. 2011;26:13-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
16. CAMPA D , Husing A, Dostal L, Stein A, et al
    Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.
    Oncol Rep. 2011 Jun 24. doi: 10.3892/or.2011.1359.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. RABIAU N , Dechelotte P, Adjakly M, Kemeny JL, et al
    BRCA1, BRCA2, AR and IGF-I expression in prostate cancer: Correlation between RT-qPCR and immunohistochemical detection.
    Oncol Rep. 2011 Jun 7. doi: 10.3892/or.2011.1339.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
18. SZLISZKA E , Krol W
    Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
    Oncol Rep. 2011 May 31. doi: 10.3892/or.2011.1332.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. WYBIERALSKA E , Szpak K, Gorecki A, Bonarek P, et al
    Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations.
    Oncol Rep. 2011 May 26. doi: 10.3892/or.2011.1321.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. GUO Z , He Y, Wang S, Zhang A, et al
    Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells.
    Oncol Rep. 2011 May 4. doi: 10.3892/or.2011.1295.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
21. LIU KC , Huang AC, Wu PP, Lin HY, et al
    Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.
    Oncol Rep. 2011 Apr 15. doi: 10.3892/or.2011.1264.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
22. DONG Z , Liu Y, Levin L, Oleksowicz L, et al
    Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
    Oncol Rep. 2011 Mar 29. doi: 10.3892/or.2011.1237.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. LIU X , Yan Z, Huang L, Guo M, et al
    Cell surface heat shock protein 90 modulates prostate cancer cell adhesion and invasion through the integrin-beta1/focal adhesion kinase/c-Src signaling pathway.
    Oncol Rep. 2011 Mar 1. doi: 10.3892/or.2011.1202.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
24. SHAIKHIBRAHIM Z , Langer B, Lindstrot A, Florin A, et al
    Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells.
    Oncol Rep. 2011 Jan 21. doi: 10.3892/or.2011.1156.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. YAMADA Y , Nakamura K, Aoki S, Tobiume M, et al
    Lactate dehydrogenase, Gleason score and HER-2 overexpression are significant prognostic factors for M1b prostate cancer.
    Oncol Rep. 2011 Jan 18. doi: 10.3892/or.2011.1154.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. ZHU H , Pan X, Qi H, Wang X, et al
    Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
    Oncol Rep. 2011;25:81-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
27. BOKOBZA SM , Ye L, Kynaston HG, Jiang WG, et al
    Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway.
    Oncol Rep. 2010;24:1653-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. ANG J , Fang BL, Ashman LK, Frauman AG, et al
    The migration and invasion of human prostate cancer cell lines involves CD151 expression.
    Oncol Rep. 2010;24:1593-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. NATHWANI SM , Cloonan SM, Stronach M, Campiani G, et al
    Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce cell cycle arrest and apoptosis in prostate cancer cells.
    Oncol Rep. 2010;24:1499-507.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
30. TERAKAWA T , Miyake H, Kumano M, Sakai I, et al
    The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cells.
    Oncol Rep. 2010;24:1395-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: